Cordex Systems Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5M

  • Investors
  • 11

Cordex Systems General Information

Description

Developer of a non-invasive early detection method designed for cardiovascular diseases. The company's device uses a patented diagnostic tool that provides both early detection and ongoing monitoring of cardiovascular disease by measuring endothelial dysfunction, thereby enabling patients to diagnose the onset of cardiovascular disease and monitor the efficacy of prescribed treatment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Corporate Office
  • 7625 Wisconsin Avenue
  • Bethesda, MD 20814
  • United States
+1 (310) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cordex Systems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 09-Mar-2017 $5M 000 Completed Generating Revenue
3. Later Stage VC 04-Feb-2015 00.00 Cancelled Generating Revenue
2. Early Stage VC 25-Sep-2013 Completed Startup
1. Grant 20-Feb-2013 $588K Completed Startup
To view Cordex Systems’s complete valuation and funding history, request access »

Cordex Systems Patents

Cordex Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2910070-T3 Method and device to detect and evaluate reactive hyperemia by segmental plethysmography Active 11-Mar-2014 0000000000
AU-2014386201-B2 Method and device for detecting and assessing reactive hyperemia using segmental plethysmography Active 11-Mar-2014 0000000000 0
AU-2014386201-A1 Method and device for detecting and assessing reactive hyperemia using segmental plethysmography Active 11-Mar-2014 0000000000
CA-2942022-A1 Method and device for detecting and assessing reactive hyperemia using segmental plethysmography Active 11-Mar-2014 0000000000
JP-6494669-B2 Method and apparatus for detecting and evaluating reactive hyperemia using segmental plethysmography Active 11-Mar-2014 A61B5/0295
To view Cordex Systems’s complete patent history, request access »

Cordex Systems Executive Team (5)

Name Title Board Seat Contact Info
Kathy Magliato MD Co-Founder, Chief Executive Officer, Chief Medical Officer & Board Member
Albert Fleury III Chief Operating Officer
Stephen Ritterbush Ph.D Co-Founder & Board Member
Michael Whitt Ph.D Co-Founder
William Wicker Chairman
To view Cordex Systems’s complete executive team members history, request access »

Cordex Systems Board Members (7)

Name Representing Role Since
David Mayer Self Board Member 000 0000
Kathy Magliato MD Cordex Systems Co-Founder, Chief Executive Officer, Chief Medical Officer & Board Member 000 0000
Neil Golub Self Board Member 000 0000
Raj Manek Self Board Member 000 0000
Stephen Ritterbush Ph.D Cordex Systems Co-Founder & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cordex Systems Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Morgan Stanley Investment Bank Minority 000 0000 000000 0
National Institutes of Health Government Minority 000 0000 000000 0
NBCUniversal Corporation Minority 000 0000 000000 0
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
Plum Alley Investments Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »